Shiavax J. Rao/X
Oct 3, 2026, 05:32
Shiavax J. Rao: PERT 2026 Session Explores Long-Term Anticoagulation and DOAC Management
Shiavax J. Rao, Trainee Council Chair and Trainee Council Member at The PERT Consortium, Cardiology Fellow at Guthrie, shared The PERT Consortium’s post on X:
“An amazing, engaging and very insightful session at PERT 2026 covering long-term anticoagulation,
DOAC de-escalation, periprocedural guidance, addressing non-adherence, transitions of care and population-based DOAC management.”
The PERT Consortium shared a post on X:
“A huge thank you to our amazing panel of experts for an insightful discussion on anticoagulation in PE!
So many important takeaways, thought-provoking questions, and opportunities to improve clinical practice.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC